Editorial comment on “Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (<scp>TATE</scp> study)”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Editorial comment on “Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)”

Published:2024-04 Issue:4 Volume:35 Page:
ISSN:0905-6157
Container-title:Pediatric Allergy and Immunology
language:en
Short-container-title:Pediatric Allergy Immunology

Author:

Cabrera‐Perez Javier S.¹,Eigenmann Philippe²^ORCID,Akenroye Ayobami¹^ORCID

Affiliation:

1. Division of Allergy and Clinical Immunology, Department of Medicine Brigham & Women's Hospital, Harvard Medical School Boston Massachusetts USA

2. Department of Pediatrics, Gynecology and Obstetrics, Pediatric Allergy Unit University Hospitals of Geneva Geneva Switzerland

Abstract

image

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pai.14128

Reference10 articles.

1. Not just small adults: the metaphors of paediatrics

2. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

3. Anti‐IL‐5 in pediatric allergic diseases

4. New perspectives of childhood asthma treatment with biologics

5. Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety (TATE study)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP